The present invention relates to a novel .alpha.-catenin with a new, specific expression pattern in mainly heart and testis. The invention further relates to the use of this .alpha.-catenin in the prediction, diagnosis, and/or treatment of cadherin-catenin related diseases, in particular cardiomyopathies and male infertility.